Community Health Systems (NYSE: CYH) SVP & CAO receives new stock and option awards
Rhea-AI Filing Summary
Community Health Systems SVP & CAO Phillip A. Posey reported multiple equity awards in the latest insider filing. On March 1, 2026, he received grants of 25,000 performance-based restricted shares, 25,000 stock options, and 25,000 shares of common stock, all at a reported price of $0.00 per share, reflecting compensation awards rather than open-market purchases.
The performance-based restricted shares will vest based on Community Health Systems’ cumulative same-store adjusted EBITDA growth and cumulative same-store net revenue growth during the 2026–2028 performance period, with between 0% and 200% of the target vesting depending on results. The time-based restricted stock and stock options vest in one-third increments on the first, second, and third anniversaries of the grant date. The filing also shows a disposition of 1,188 shares of common stock at $3.46 per share to cover tax liabilities, leaving Posey with 51,736 common shares held directly after these transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Performance Based Restricted | 25,000 | $0.00 | -- |
| Grant/Award | Stock Options (Right to Buy) | 25,000 | $0.00 | -- |
| Grant/Award | Common Stock | 25,000 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,188 | $3.46 | $4K |
Footnotes (1)
- The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period. Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.
